{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:10Z","timestamp":1778657530442,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIC SC 006537"],"award-info":[{"award-number":["ZIC SC 006537"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11060-020-03627-0","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T08:04:05Z","timestamp":1602403445000},"page":"437-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-772X","authenticated-orcid":false,"given":"Sean J.","family":"Hipp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aradhana","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra","family":"Krauze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Citrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Glod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna H.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema","family":"Sethumadhavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Garvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Glade-Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias A.","family":"Karajannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Odabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis T.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin A.","family":"Camphausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Douglas","family":"Figg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,11]]},"reference":[{"key":"3627_CR1","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","volume":"28","author":"B Paugh","year":"2010","unstructured":"Paugh B, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax D, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison D, Grundy R, Baker S (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061\u20133068","journal-title":"J Clin Oncol"},{"key":"3627_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-013-1104-8","volume":"113","author":"J Fangusaro","year":"2013","unstructured":"Fangusaro J, Warren K (2013) Unclear standard of care for pediatric high grade glioma patients. J Neurooncol 113:341\u2013342","journal-title":"J Neurooncol"},{"key":"3627_CR3","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.ejca.2006.05.018","volume":"42","author":"R Sharma","year":"2006","unstructured":"Sharma R, Steward W, Daines C, Knight R, O\u2019Byrne K, Dalgleish A (2006) Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies. Eur J Cancer 42:2318\u20132325","journal-title":"Eur J Cancer"},{"key":"3627_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10637-007-9107-y","volume":"26","author":"P Patel","year":"2008","unstructured":"Patel P, Kondagunta G, Schwartz L, Ishill N, Bacik J, DeLuca J, Russo P, Motzer R (2008) Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma. Investig New Drugs 26:273\u2013276","journal-title":"Investig New Drugs"},{"key":"3627_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1200\/JCO.2010.30.8387","volume":"29","author":"S Berg","year":"2011","unstructured":"Berg S, Cairo M, Russell H, Ayello J, Ingle A, Lau H, Chen N, Adamson P, Blaney S (2011) Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed\/refractory solid tumors or myelodysplastic syndrome: a Children\u2019s Oncology Group Phase I Consortium report. J Clin Oncol 29:316\u2013323","journal-title":"J Clin Oncol"},{"key":"3627_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1200\/JCO.2010.31.3601","volume":"29","author":"K Warren","year":"2011","unstructured":"Warren K, Goldman S, Pollack I, Fangusaro J, Schaiquevich P, Stewart C, Wallace D, Blaney S, Packer R, Macdonald T, Jakacki R, Boyett J, Kun L (2011) Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. J Clin Oncol 29:324\u2013329","journal-title":"J Clin Oncol"},{"key":"3627_CR7","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1158\/1078-0432.CCR-07-1546","volume":"13","author":"H Fine","year":"2007","unstructured":"Fine H, Kim L, Albert P, Duic J, Ma H, Zhang W, Tohnya T, Figg W, Royce C (2007) A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors. Clin Cancer Res 13:7101\u20137106","journal-title":"Clin Cancer Res"},{"issue":"2 Pt 1","key":"3627_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1078-0432.743.11.2","volume":"11","author":"R Ansiaux","year":"2005","unstructured":"Ansiaux R, Baudelet C, Jordan B, Beghein N, Sonveaux P, De Wever J, Martinive P, Gr\u00e9goire V, Feron O, Gallez B (2005) Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 11(2 Pt 1):743\u2013750","journal-title":"Clin Cancer Res"},{"key":"3627_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2008.03.046","volume":"73","author":"J Drappatz","year":"2009","unstructured":"Drappatz J, Wong E, Schiff D, Kesari S, Batchelor T, Doherty L, Lafrankie D, Ramakrishna N, Weiss S, Smith S, Ciampa A, Zimmerman J, Ostrowsky L, David K, Norden A, Barron L, Sceppa C, Black P, Wen P (2009) A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 73:222\u2013227","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3627_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1570-0232(04)00666-X","volume":"811","author":"TM Tohnya","year":"2004","unstructured":"Tohnya TM, Hwang K, Lepper ER, Fine HA, Dahut WL, Venitz J, Sparreboom A, Figg WD (2004) Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography\u2013mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 811(2):135\u2013141","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03627-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T22:35:58Z","timestamp":1669156558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03627-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3627"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03627-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}